Company News

Latest News

Polaris Pharmaceuticals applies for the first listing
Polaris Group (TWSE:6550) rush to the stock exchange to apply for the first listing of shares before...
Read more »
Polaris Group has entered into an agreement with the University of California,Irvine(UCI) to develop a Universal Influenza and Coronavirus Vaccine.
Polaris Group has entered into an agreement with the University of California,Irvine(UCI) to develop...
Read more »
Polaris Announces Dr. Philip Felgner Joins the Team
Polaris Group (TWSE:6550) announced today that Dr. Philip Felgner of the University of California, Irvine...
Read more »
Polaris Announces Dr. Yali Tsai Joins the Team
Polaris Pharmaceuticals announced today that Dr. Yali Tsai has joined Polaris as Vice President of Gene...
Read more »
Polaris Announces Launch of World's First Phase III Clinical Trial of Genetic Markers for Liver Cancer
Polaris Group (TWSE:6550) held its 2021 Annual General Meeting on August 23, announcing the launch of...
Read more »
Polaris-Press Release-FDA Response to DSMB Recommendation-5 August 2021
After consultation with FDA, Polaris will follow Data and Safety Monitoring Board’s (DSMB) recommendation...
Read more »
1 … 3 4 5 6
Scroll to Top
This site is registered on wpml.org as a development site.